TY - JOUR
T1 - The human secretome atlas initiative
T2 - Implications in health and disease conditions
AU - Brown, Kristy J.
AU - Seol, Haeri
AU - Pillai, Dinesh K.
AU - Sankoorikal, Binu John
AU - Formolo, Catherine A.
AU - Mac, Jenny
AU - Edwards, Nathan J.
AU - Rose, Mary C.
AU - Hathout, Yetrib
N1 - Funding Information:
This work was partially supported by NIH grant K12 HL090020-05 and NIH core grants: NCMRR/NINDS 2R24HD050846-06 (National Center for Medical Rehabilitation Research) and IDDRC 5P30HD040677-10 (Intellectual and Developmental Disabilities Research Center) and by NIH NCRR UL1RR031988 (GWU-CNMC CTSI). The authors would like to thank Dr. Jyoti Jaiswal for his helpful discussion and inputs.
PY - 2013
Y1 - 2013
N2 - Proteomic analysis of human body fluids is highly challenging, therefore many researchers are redirecting efforts toward secretome profiling. The goal is to define potential biomarkers and therapeutic targets in the secretome that can be traced back in accessible human body fluids. However, currently there is a lack of secretome profiles of normal human primary cells making it difficult to assess the biological meaning of current findings. In this study we sought to establish secretome profiles of human primary cells obtained from healthy donors with the goal of building a human secretome atlas. Such an atlas can be used as a reference for discovery of potential disease associated biomarkers and eventually novel therapeutic targets. As a preliminary study, secretome profiles were established for six different types of human primary cell cultures and checked for overlaps with the three major human body fluids including plasma, cerebrospinal fluid and urine. About 67% of the 1054 identified proteins in the secretome of these primary cells occurred in at least one body fluid. Furthermore, comparison of the secretome profiles of two human glioblastoma cell lines to this new human secretome atlas enabled unambiguous identification of potential brain tumor biomarkers. These biomarkers can be easily monitored in different body fluids using stable isotope labeled standard proteins. The long term goal of this study is to establish a comprehensive online human secretome atlas for future use as a reference for any disease related secretome study. This article is part of a Special Issue entitled: An Updated Secretome.
AB - Proteomic analysis of human body fluids is highly challenging, therefore many researchers are redirecting efforts toward secretome profiling. The goal is to define potential biomarkers and therapeutic targets in the secretome that can be traced back in accessible human body fluids. However, currently there is a lack of secretome profiles of normal human primary cells making it difficult to assess the biological meaning of current findings. In this study we sought to establish secretome profiles of human primary cells obtained from healthy donors with the goal of building a human secretome atlas. Such an atlas can be used as a reference for discovery of potential disease associated biomarkers and eventually novel therapeutic targets. As a preliminary study, secretome profiles were established for six different types of human primary cell cultures and checked for overlaps with the three major human body fluids including plasma, cerebrospinal fluid and urine. About 67% of the 1054 identified proteins in the secretome of these primary cells occurred in at least one body fluid. Furthermore, comparison of the secretome profiles of two human glioblastoma cell lines to this new human secretome atlas enabled unambiguous identification of potential brain tumor biomarkers. These biomarkers can be easily monitored in different body fluids using stable isotope labeled standard proteins. The long term goal of this study is to establish a comprehensive online human secretome atlas for future use as a reference for any disease related secretome study. This article is part of a Special Issue entitled: An Updated Secretome.
UR - http://www.scopus.com/inward/record.url?scp=84884649534&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884649534&partnerID=8YFLogxK
U2 - 10.1016/j.bbapap.2013.04.007
DO - 10.1016/j.bbapap.2013.04.007
M3 - Article
C2 - 23603790
AN - SCOPUS:84884649534
SN - 1570-9639
VL - 1834
SP - 2454
EP - 2461
JO - Biochimica et Biophysica Acta - Proteins and Proteomics
JF - Biochimica et Biophysica Acta - Proteins and Proteomics
IS - 11
ER -